Michael Seres joins Monmouth’s Advisory Board

Monmouth is thrilled to have Michael Seres join our Advisory Board.  Michael’s passion for, and personal experience of, patient engagement will add first-rate insight to our organisation.  In 2012 Michael founded 11Health, a health and technology company.  After being given a stoma as part of transplant he developed the first sensor technology for stoma and urology patients.
Michael was diagnosed aged 12 with the incurable bowel condition Crohn’s Disease. In late 2011 he became the 11th person to undergo a small bowel transplant in the UK at The Churchill Hospital in Oxford.
He started blogging about his journey through Bowel Transplant. His blog has over 95,000 followers and he uses social media to develop global on line peer to peer communities covering over 25,000 patients. He devises social media strategies around patient engagement. Michael mentors patients and their families; is a published author & professional speaker.
He is the patient lead for #NHSSM, a facilitator for Centre for Patient Leadership & digital strategy advisor to The Patients Association & Oxford Transplant Foundation.

Latest content:


NHS services under pressure – What legacy will Covid-19 leave?

Back in August we looked at the impact of the pandemic on NHS cancer services. The concern then was that patients were not being seen or treated quickly enough or in some cases, given the drop-off in activity, not being diagnosed in the first place. Given the false dawn lull in Covid cases back in the summer, now all too clearly the calm before the storm, what is the situation now?

Read More »
Please accept [renew_consent]%cookie_types[/renew_consent] cookies to watch this video.

Tracking the Pandemic and its impact